St. Louis Blues support cross-county bike relay to fund cancer research
There was a lot to cheer outside Enterprise Center Tuesday morning. Riders ready to brave their bikes with the St. Louis ...
Bristol Myers, 2seventy bio halt enrollment in Abecma late-stage trial
(TSVT) stock lost as company with Bristol Myers Squibb (BMY) plan to discontinue enrollments in a Phase 3 trial for cancer ...
Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting
An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Shares of Bristol Myers Squibb Co. BMY rallied 1.86% to $50.94 Tuesday, on what proved to be an all-around favorable trading ...
BlackDoctor19h
Make Your Voice Heard: FDA Mandate Episode #3
Curious about the FDA's mandate for diversity in clinical trials? Now's the opportunity to make your voice heard.
Le Lézard2h
Craig Gentry, Renowned Cryptographer, Joins Cornami as Chief Scientist, Algorithms
Cornami named for a "tsunami of cores" is pleased to announce that Dr. Craig Gentry has joined the company as its Chief Scientist, Algorithms. Dr. Gentry brings a wealth of knowledge and experience in ...
Wall Street Journal16h
Bristol Myers Squibb Co.
1 Day BMY 1.84% DJIA 0.72% S&P 500 0.54% Health Care/Life Sciences -0.83% ...